Mumps in Poland in 2017 / Świnka w Polsce w 2017 roku
Journal Title: Przegląd Epidemiologiczny - Year 2019, Vol 73, Issue 3
Abstract
BACKGROUND. Vaccination against mumps from 2003 is mandatory in Poland and given as two dose scheme with MMR vaccine (mumps, measles, and rubella). Earlier this vaccination was only recommended. Despite observed decline in mumps incidence for over a decade which is a result of conducted vaccinations, mumps is still a common disease among the children. AIM. To assess epidemiological situation of mumps in Poland in 2017, including vaccination coverage in Polish population, in comparison to previous years. METHODS. The descriptive analysis was based on data retrieved from routine mandatory surveillance system and published in the annual bulletins “Infectious diseases and poisonings in Poland in 2017” and “Vaccinations in Poland in 2017”. RESULTS. In total, there were 1 670 mumps cases registered in Poland in 2017. Incidence of mumps was 4.3 per 100,000 and it was lower in comparison with 2016. The highest incidence (5.5 per 100 000) was registered in Małopolskie voivodeship and the lowest (3.0) – in Świętokrzyskie voivodeship. The highest incidence rate was observed among children aged 6 years (32.5 per 100 000). Incidence in men (5.1 per 100 000) was higher than in women (3.6). In 2017, 37 people were hospitalized due to mumps. Vaccination coverage of children aged 3 years in Poland in 2017 was 94,0% and it was lower by 1.5% in comparison with year 2016. CONCLUSIONS. Systematic execution of mumps vaccination in accordance with the National Immunisation Programme resulted in a significant decrease in the number of registered cases. Due to the high vaccination coverage further decline in the number of cases is expected.
Authors and Affiliations
Joanna Bogusz, Iwona Paradowska-Stankiewicz
Effectiveness of single medical advice on emergency phone numer knowledge in urban adult population – „Health, Alcohol and Psychosocial Factors in Eastern Europe” substudy
INTRODUCTION. Early access to Emergency Medical Services determines survival in out-of-hospital cardiac arrest. However, a significant proportion of adults do not know the emergency phone number (EN) and no intervention...
Znaczenie stężenia sCD40 i sCD40L u chorych z przewlekłym zakazeniem HCV i koinfekcją HIV
Receptor CD40 pobudzany jest przez ligand CD40L (CD154) syntetyzowany w stanie zapalnym przez NK, monocyty i limfocyty B. Pobudzenie CD40 aktywuje w komórkach proteiny TRAF, które pobudzają różne szlaki enzymatyczne. Wys...
Inequalities in health and social policy
WHO oraz Komisja Europejska przykładają dużą wagę do promocji działań mających na celu zmniejszenie nierówności w zdrowiu. W artykule podniesiono problemy metodologiczne badań nad przyczynami nierówności w zdrowiu. Autor...
Epidemiologia zakażeń HCV w Europie Środkowej i Południowo-Wschodniej
CELEM PRACY jest oszacowanie rozpowszechnienia zakażeń HCV w 14 krajach Europy Środkowej i Wschodniej. MATERIAŁ I METODY. W pracy zaprezentowano dane porównawcze dotyczące osób, u których wykryto obecność przeciwciał ant...
Rubella in Poland in 2013
BACKGROUND. In 2004, Poland has adopted the WHO goal of rubella elimination and congenital rubella syndrome prevention. The main target of the Programme is to stop transmission of the virus in the environment and prevent...